| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 09/03/2009 | US20090221575 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 09/03/2009 | US20090221574 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 09/03/2009 | US20090221573 Use of Activators of Soluble Guanylate Cyclase for Promoting Wound Healing |
| 09/03/2009 | US20090221572 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/03/2009 | US20090221571 Hiv integrase inhibitors |
| 09/03/2009 | US20090221568 Synthesis of Inhibitors of FtsZ |
| 09/03/2009 | US20090221567 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease |
| 09/03/2009 | US20090221556 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods |
| 09/03/2009 | US20090221555 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/03/2009 | US20090221425 Method of protecting a plant propagation material, a plant, and/or plant organs |
| 09/03/2009 | US20090221424 Pesticides |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090218039 Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound |
| 09/03/2009 | CA2716855A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | CA2716599A1 Glucokinase activators |
| 09/03/2009 | CA2716365A1 Heterocyclic urea derivatives and methods of use thereof-211 |
| 09/03/2009 | CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | CA2714607A1 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2094683A2 Bicyclic compounds and use as antidiabetics |
| 09/02/2009 | EP2094673A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | EP2094669A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 09/02/2009 | EP2094662A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 09/02/2009 | EP1888574B1 New antibiotic derivatives |
| 09/02/2009 | EP1758860B1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1300395B1 4-substituted piperidine compound |
| 09/02/2009 | CN101522672A Insecticidal isoxazolines |
| 09/02/2009 | CN101522671A Salts of 5 - ( l ( s ) -amino - 2 - hydroxyethyl ) -n- [ ( 2, 4 -difluorophenyl) -methyl] - 2 - [ 8 -methoxy - 2 - (trifluoromethyl) - 5 - quinoline] - 4 - oxazolecarboxamide, toluenesulfonate, fumara |
| 09/02/2009 | CN101522670A Pyridin-3-yl derivatives as immunomodulating agents |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582755 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582661 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; 2-Amino-5-chloro-phenyl)-(3-methyl-pyridin-4-yl)-methanone |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
| 09/01/2009 | US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | US7582629 2-tert-butyl-4-[(4-morpholin-4-ylphenyl)amino]-5-phenylisothiazol-3(2H)-one 1,1-dioxide; modulation of nuclear hormone receptors Liver X Receptor; cardiovascular diseases: atherosclerosis; antiinflammatory agent; Alzheimer's disease, antidiabetic agent; insulin resistance, metabolic disorders |
| 09/01/2009 | US7582628 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 09/01/2009 | US7582589 3-carbonylaminothiophenes and their use as fungicides |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 08/27/2009 | WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | WO2009105214A2 Selective androgen receptor modulators |
| 08/27/2009 | WO2009104990A1 2,4-diaminopyridine derivatives, a pharmaceutical composition and a medicinal agent which are based thereon and used for treating or preventing diseases and disturbances caused by the hyperactivation of nmda-receptors and/or in the form of cognitive function stimulators and a method for the use thereof |
| 08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | WO2009104802A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2009 | WO2009104729A1 Amide derivative and pharmaceutical composition containing the same |
| 08/27/2009 | WO2009104159A1 Oxazolidinone derivatives |
| 08/27/2009 | WO2009103966A1 Bicyclylaryl-aryl-amine compounds and their use |
| 08/27/2009 | WO2009103719A1 Substituted 4-(indol-3-yl)quinazolines and use and production thereof |
| 08/27/2009 | WO2009103652A1 Modulators for amyloid beta |
| 08/27/2009 | WO2009103626A1 4, 5-dihydro-oxazol-2-yl amine derivatives |
| 08/27/2009 | WO2009103439A1 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 08/27/2009 | WO2009103432A2 Covalently binding imaging probes |
| 08/27/2009 | WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | WO2009074231A3 Insecticidal imino heterocycles |
| 08/27/2009 | WO2009012280A3 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 08/27/2009 | WO2008116145A3 Soluble epoxide hydrolase inhibitors |
| 08/27/2009 | US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/27/2009 | US20090216014 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090216009 Process for the production of ezetimibe and intermediates used in this process |
| 08/27/2009 | US20090215834 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/27/2009 | US20090215822 Substituted Oxadiazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate Receptors |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215779 Oxadiazole derivatives as dgat inhibitors |
| 08/27/2009 | US20090215777 Pyrimidine Derivatives As HSP90 Inhibitors |
| 08/27/2009 | US20090215776 Organic compounds |
| 08/27/2009 | US20090215773 Dihydropyridine derivatives |
| 08/27/2009 | US20090215772 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 08/27/2009 | US20090215770 Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases |
| 08/27/2009 | US20090215768 Isoxazole derivatives and pharmaceutical compositions comprising the same |
| 08/27/2009 | US20090215767 Isoflavone derivatives and pharmaceutical compositions comprising the same |